Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00853515 · ClinicalTrials.gov registry record · NA
Goal-directed Fluid Resuscitation in Acute Pancreatitis
A NA study, sponsored by Brigham and Women's Hospital.
- Terminated
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT00853515 is a NA study that was terminated before completion, run by Brigham and Women's Hospital. The registered enrollment target is 40 participants.
The verdict
NCT00853515, a NA study, was terminated before completion, sponsored by Brigham and Women's Hospital.
- TERMINATED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
Vigorous fluid resuscitation is currently believed to play a key role in reducing complications associated with acute pancreatitis. However, aggressive fluid replacement can be associated with complications such as pulmonary fluid sequestration. The purpose of this study is to evaluate alternative approaches to early fluid resuscitation for patients with acute pancreatitis.
Interventions
- OTHER Goal-directed fluid resuscitation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2009-03 |
| Est. Completion | 2010-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00853515
The ClinicalTrials.gov registry entry for NCT00853515 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Goal-directed fluid resuscitation is the first listed.
NCT00853515 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00853515 about?
NCT00853515 is a clinical study titled "Goal-directed Fluid Resuscitation in Acute Pancreatitis". Vigorous fluid resuscitation is currently believed to play a key role in reducing complications associated with acute pancreatitis. However, aggressive fluid replacement can be associated with complications such as pulmonary fluid sequestration. The purpose of this study is to evaluate alternative a...
What is the current status of trial NCT00853515?
This trial is currently terminated. It is a NA study. The enrollment target is 40 participants. The study started on 2009-03. Estimated completion is 2010-06.
What interventions are being tested in trial NCT00853515?
The interventions under investigation include: Goal-directed fluid resuscitation (OTHER).
Who is sponsoring clinical trial NCT00853515?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.